Vir Biotechnology (VIR) Return on Capital Employed Growth (1y) (2020 - 2026)
Vir Biotechnology (VIR) Return on Capital Employed Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 2,400.00 |
| 10 | Vir Biotechnology | 1.30 Bn | 1.30 Bn | - | 299.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299.00 |
| Dec 31, 2025 | -801.00 |
| Sep 30, 2025 | -1,170.00 |
| Jun 30, 2025 | -1,844.00 |
| Mar 31, 2025 | -1,794.00 |
| Dec 31, 2024 | -630.00 |
| Sep 30, 2024 | -637.00 |
| Jun 30, 2024 | -2,043.00 |
| Mar 31, 2024 | -2,082.00 |
| Dec 31, 2023 | -7,510.00 |
| Sep 30, 2023 | -10,136.00 |
| Jun 30, 2023 | -7,153.00 |
| Mar 31, 2023 | -10,713.00 |
| Dec 31, 2022 | 332.00 |
| Sep 30, 2022 | 9,502.00 |
| Jun 30, 2022 | 8,834.00 |
| Mar 31, 2022 | 15,032.00 |
| Dec 31, 2021 | 6,960.00 |
| Sep 30, 2021 | 571.00 |
| Jun 30, 2021 | 998.00 |